Collectively, our findings provided a novel understanding for peripheral CB1R's role in the modulation of body weight and glucose homeostasis and highlight peripheral CB1R as well as Cav1.1 in the SM as potential targets for obesity treatment. The gene discussed is CACNA1S; the disease is obesity due to melanocortin 4 receptor deficiency.